Omnicell, Inc. (OMCL)
NASDAQ: OMCL · Real-Time Price · USD
31.35
-0.19 (-0.60%)
Aug 13, 2025, 4:00 PM - Market closed
Omnicell Employees
Omnicell had 3,670 employees as of December 31, 2024. The number of employees increased by 20 or 0.55% compared to the previous year.
Employees
3,670
Change (1Y)
20
Growth (1Y)
0.55%
Revenue / Employee
$313,223
Profits / Employee
$6,291
Market Cap
1.44B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
OMCL News
- 12 days ago - Omnicell, Inc. (OMCL) Q2 2025 Earnings Conference Call Transcript - Seeking Alpha
- 13 days ago - Omnicell Q2 Earnings: Market Ignoring The Segments - Seeking Alpha
- 14 days ago - Omnicell Announces Second Quarter 2025 Results - Business Wire
- 4 weeks ago - Omnicell to Release Second Quarter 2025 Financial Results on July 31, 2025 - Business Wire
- 3 months ago - Omnicell Expects Improved Profitability, Updates Second Quarter and Full Year 2025 Profit Outlook and Announces a New Stock Repurchase Program - Business Wire
- 3 months ago - Omnicell Announces New Products for Perioperative and Clinic Settings - Business Wire
- 3 months ago - Omnicell Opens New Innovation Lab in Austin, Texas - Business Wire
- 3 months ago - Omnicell: Facing New Headwinds - Seeking Alpha